May 14, 2026 02:00PM

Apr 21, 2026 08:52AM

Apr 19, 2026 07:00PM

Apr 19, 2026 07:00PM

Mar 30, 2026 05:08AM

Mar 27, 2026 04:37PM

Mar 27, 2026 04:30PM Raymond James Reiterates Outperform Rating on Monopar Therapeutics (MNPR) following Q4 results

Mar 27, 2026 01:00PM

Mar 2, 2026 08:04AM

Mar 2, 2026 08:00AM

Jan 21, 2026 06:56AM

Jan 14, 2026 04:23AM

Jan 7, 2026 01:17PM

Nov 13, 2025 08:00AM Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

Oct 13, 2025 05:30AM

Oct 10, 2025 07:24AM

Oct 6, 2025 05:31AM

Sep 24, 2025 03:53PM

Sep 9, 2025 08:12AM

Aug 12, 2025 08:00AM

Jun 23, 2025 05:03AM Chardan Capital Markets Starts Monopar Therapeutics (MNPR) at Buy, PT $60

Jun 11, 2025 07:00AM

May 13, 2025 08:00AM

Mar 31, 2025 08:00AM

Mar 19, 2025 04:20AM

Nov 11, 2024 07:25AM

Nov 8, 2024 08:00AM

Jun 1, 2023 07:00AM Monopar Therapeutics (MNPR) Reports Encouraging Camsirubicin Phase 1b Trial Update

Jun 1, 2023 07:00AM

Mar 27, 2023 05:02PM

Mar 27, 2023 05:00PM

Mar 27, 2023 05:00PM

Oct 5, 2022 08:00AM

Oct 5, 2022 08:00AM

Mar 24, 2022 08:00AM Monopar Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Developments

Mar 24, 2022 08:00AM

Feb 15, 2022 08:05AM

Feb 15, 2022 08:05AM

Feb 15, 2022 08:05AM

Nov 12, 2021 08:00AM

Nov 12, 2021 08:00AM

Oct 27, 2021 08:05AM Monopar Announces First Patient Dosed in Phase 1b Trial Evaluating Camsirubicin for the Treatment of Advanced Soft Tissue Sarcoma

Oct 27, 2021 08:05AM

Aug 12, 2021 08:00AM

Aug 12, 2021 08:00AM

Aug 5, 2021 08:00AM

Aug 5, 2021 08:00AM

Aug 3, 2021 08:12AM

Aug 3, 2021 08:00AM Monopar Announces FDA Clearance to Proceed with Camsirubicin Clinical Trial Targeting Advanced Soft Tissue Sarcoma

Aug 3, 2021 08:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All